Identification and characterization of <i>in silico</i>, <i>in vivo</i>, <i>in vitro</i>, and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation and <i>in silico</i> toxicity studies of its metabolites
RSC advances